Publication | Closed Access

Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

OncologyMedicineIntravenous L-alanyl-l-glutamineOral MedicinePlacebo-controlled TrialHead And Neck CancerOral MucositisNeck OncologyPharmacologyRadiation OncologyOral CancerHealth Sciences